The membrane trafficking and functionality of the K+-Cl- co-transporter KCC2 is regulated by TGF-beta 2 by Roussa, Eleni et al.
RESEARCH ARTICLE
The membrane trafficking and functionality of the K
+
-Cl
−
co-transporter KCC2 is regulated by TGF-β2
Eleni Roussa1,2,*, Jan Manuel Speer1, Ilona Chudotvorova1, Shokoufeh Khakipoor1, Sergei Smirnov3,
Claudio Rivera3 and Kerstin Krieglstein1,*
ABSTRACT
Functional activation of the neuronal K+-Cl− co-transporter KCC2
(also known as SLC12A5) is a prerequisite for shifting GABAA
responses from depolarizing to hyperpolarizing during development.
Here, we introduce transforming growth factor β2 (TGF-β2) as a new
regulator of KCC2 membrane trafficking and functional activation.
TGF-β2 controls membrane trafficking, surface expression and
activity of KCC2 in developing and mature mouse primary
hippocampal neurons, as determined by immunoblotting,
immunofluorescence, biotinylation of surface proteins and KCC2-
mediated Cl− extrusion. We also identify the signaling pathway from
TGF-β2 to cAMP-response-element-binding protein (CREB) and
Ras-associated binding protein 11b (Rab11b) as the underlying
mechanism for TGF-β2-mediated KCC2 trafficking and functional
activation. TGF-β2 increases colocalization and interaction of KCC2
with Rab11b, as determined by 3D stimulated emission depletion
(STED) microscopy and co-immunoprecipitation, respectively,
induces CREB phosphorylation, and enhances Rab11b gene
expression. Loss of function of either CREB1 or Rab11b suppressed
TGF-β2-dependent KCC2 trafficking, surface expression and
functionality. Thus, TGF-β2 is a new regulatory factor for KCC2
functional activation and membrane trafficking, and a putative
indispensable molecular determinant for the developmental shift of
GABAergic transmission.
KEY WORDS: KCC2, CREB, Growth factor, Neuronal development,
Rab11b
INTRODUCTION
Regulation of KCC2 (also known as SLC12A5), the neuron-
specific electroneutral K+-Cl− co-transporter, is crucial for
development and maturation of GABAergic neurotransmission. In
immature central nervous system (CNS) neurons, γ-aminobutyric
acid (GABA) produces depolarizing postsynaptic potentials, which
are likely involved in stabilizing synapses during development
(Ben-Ari, 2002; Blaesse et al., 2009). GABA-mediated
depolarization is sustained through a high expression of NKCC1
(also known as SLC12A2), a cation-chloride co-transporter
that mediates intracellular Cl− accumulation above its
electrochemical equilibrium. During maturation of most central
neurons, however, expression of the Cl− extruder KCC2 is
upregulated resulting in an intracellular Cl− concentration below
its electrochemical equilibrium, thereby shifting GABAA responses
from depolarizing to hyperpolarizing (Rivera et al., 1999). The
mechanisms underlying KCC2 regulation have been extensively
investigated but still are not fully understood. Brain-derived
neurotrophic factor (BDNF) has been shown to upregulate KCC2
expression in immature neurons, whereas in mature neurons
BDNF–TrkB signaling results in an activity-dependent decrease
of KCC2 expression (Rivera et al., 2002, 2004). Accordingly,
KCC2 expression is decreased in early postnatal TrkB-deficient
mice (Carmona et al., 2006). However, recent observations have
challenged the dominant role of BDNF in the developmental
upregulation of KCC2 by demonstrating that BDNF, although a
potent regulator, is not a necessary molecular determinant for the
required KCC2 upregulation during development (Puskarjov et al.,
2015). Indeed, other trophic factors, such as neurturin, also possess
the ability to regulate this transporter (Ludwig et al., 2011).
KCC2 functionality is achieved not only through transcriptional
control, but also through regulation of KCC2 membrane trafficking,
integration and stabilization in the membrane. KCC2 protein
(de)phosphorylation is thought to be a crucial regulatory
mechanism for KCC2 surface expression, surface stability and
trafficking. Apparently, the functional consequences of
phosphorylation on KCC2 depend on the specific residue
(reviewed by Kahle et al., 2013). Along this line, PKC-dependent
phosphorylation of KCC2 at S940 increases its cell surface
expression and promotes KCC2 membrane stability in cultured
hippocampal neurons (Lee et al., 2007), whereas WNK-kinase-
dependent phosphorylation at T906 and T1007 inhibits KCC2
transport function (Rinehart et al., 2009). In contrast, Src-mediated
Y903 and/or Y1087 phosphorylation regulates the membrane
trafficking of KCC2 and decreases the cell surface stability of
KCC2 by enhancing its lysosomal degradation (Lee et al., 2010).
Besides (de)phosphorylation, other molecular pathways that affect
KCC2membrane trafficking in immature neurons include TrkB and
5-HT2A serotonin receptors (Khirug et al., 2005, 2010; Bos et al.,
2013), whereas for mature neurons the molecular mechanisms
underlying KCC2 membrane trafficking need to be elucidated.
TGF-βs are multifunctional, extracellular signaling molecules
that exert a wide range of biological responses on different cell
types, including cells of the nervous system. In the CNS, TGF-βs are
required for cell fate decisions (Farkas et al., 2003; Lu et al., 2005;
Roussa et al., 2006, 2008) and regulate neuronal survival and
apoptosis during nervous system development (Dünker and
Krieglstein, 2000; Krieglstein et al., 2000). Furthermore, anReceived 29 March 2016; Accepted 2 August 2016
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impact of TGF-βs on synaptogenesis, neural network function and
neuronal plasticity has been shown (Krieglstein et al., 2011). Early
studies have documented effects such as a TGF-β1-induced long-
term facilitation in Aplysia sensory-motor synapses and increase in
neuronal excitability (Zhang et al., 1997; Chin et al., 1999), effects
mediated through activation of MAPK signaling (Chin et al., 2006)
and modulation of synapsin distribution by phosphorylation (Chin
et al., 2002). TGF-β2 has been also identified as a local modulator of
the neuromuscular junction through the control of presynaptic
quantal size (Fong et al., 2010). The TGF-β isoforms, namely TGF-
β1, TGF-β2 and TGF-β3, exhibit a distinct spatial and temporal
expression pattern and, although targeted mutations of individual
TGF-β genes are lethal, the phenotypes are distinct and isoform-
specific. Tgfb2−/− mutants die at birth due to congenital cyanosis,
yet cardiovascular and pulmonary causes of lethality have been
excluded (Sanford et al., 1997). Interestingly, impaired synaptic
transmission of spontaneous GABAergic or glycinergic, and
glutamatergic postsynaptic currents in the respiratory control area,
the pre-Bötzinger complex (preBötC), has been demonstrated
(Heupel et al., 2008).
In the present study, we show that TGF-β2 can control KCC2
trafficking and activity in mature hippocampal neurons. We also
identify the signaling pathway TGF-β2–CREB–Rab11b as the
underlying mechanism for TGF-β2-mediated KCC2 trafficking and
activity. Our results introduce TGF-β2 as a new regulator of KCC2
functionality and as putative crucial determinant for the
developmental shift of GABAergic transmission.
RESULTS
KCC2 membrane trafficking is controlled by TGF-β2
The mechanisms regulating KCC2 membrane expression and
activity are complicated but appear to involve signaling induced
by trophic factors (Rivera et al., 2002, 2004; Ludwig et al., 2011).
With this in mind, we first addressed the question of whether TGF-
β2 regulates KCC2 mRNA and protein expression during neuronal
development. Hippocampal neurons were isolated at embryonic day
(E)18.5 and cultured for 12 or 18 days in vitro (DIV). As shown in
Fig. 1A, KCC2 transcript expression (397 bp) was detectable in
neurons cultured for 12 days (Rivera et al., 2002; Ludwig et al.,
2003) and a 60-min pulse of TGF-β2 did not further increase KCC2
transcript expression (Fig. 1A). However, TGF-β2 treatment of the
cultures induced a ∼270-kDa KCC2 band (Fig. 1B). In contrast,
NKCC1 (Fiumelli and Woodin, 2007) transcript (235 bp; Fig. 1C)
and protein expression (Fig. 1D) remained unchanged following a
60-min pulse of TGF-β2. In more mature neurons, cultured for
18 days (Dotti et al., 1988), application of TGF-β2 for 60 min had
no effect on KCC2 transcript (Fig. 1E) and protein expression
(Fig. 1F).
We next investigated the cellular localization of KCC2 in
response to the TGF-β2 treatment, using DIV12 and DIV18
cultures. As shown in Fig. 2A, KCC2 immunoreactivity under
control conditions at DIV12 was predominantly associated with
small intracellular vesicles which partly colocalized with the Golgi
marker Golgi58k (asterisk). A 60-min TGF-β2 pulse cleared the
majority of these KCC2 immunoreactive vesicles from intracellular
stores and shifted immunoreactivity to the cell membrane (arrows).
The quantification shown in Fig. 2B revealed that TGF-β2 treatment
significantly reduced KCC2–Golgi58K colocalization (P=0.0015,
n=4), Moreover, immunoblotting following biotinylation of cell
surface proteins showed a significant increase for both the
KCC2∼135-kDa and ∼270-kDa band (P=0.014, n=3, Fig. 2C),
but not for NKCC1 (Fig. 2D) upon TGF-β2 treatment at DIV12.
In 18-day-old cultures (Fig. 3A,B), following TGF-β2 treatment
for 60 min, KCC2–Golgi58K colocalization was significantly
reduced (P=0.0084, n=4). Immunoblotting following biotinylation
of cell surface proteins (Fig. 3C) showed no significant differences
for both the KCC2∼135-kDa and ∼270-kDa band upon TGF-β2
treatment at DIV18. Given that TGF-β is endogenously expressed in
hippocampal neurons, we treated the cultures either with TGF-β2 or
with anti-TGF-β, a TGF-β function-blocking antibody, at DIV12
and DIV15, and assessed KCC2 immunoreactivity at DIV18
(Fig. 3D). Representative line scans from cells under each
experimental condition illustrate the distribution profile for KCC2
(red) and Golgi58k (green) immunoreactivity. Peaks of KCC2
labeling were detected in the periphery of cell bodies of control
and TGF-β2-treated cells, suggesting membrane labeling, whereas
after neutralizing endogenous TGF-β, KCC2 was exclusively
intracellularly distributed.
Taken together, these results provide the first evidence for a TGF-
β2-dependent trafficking of KCC2 from the Golgi to the cell
membrane in developing and mature neurons. These changes might
induce a functional activation of KCC2.
Functional expression of KCC2 is controlled by TGF-β2
TGF-β2-dependent translocation of KCC2 to the cell membrane in
developing neurons does not necessarily imply functional
integration of KCC2. We therefore investigated whether TGF-β2
could activate KCC2 by means of altering efficacy of KCC2-
mediated Cl− extrusion in hippocampal neurons. To do this, whole-
cell patch-clamp recordings were taken from primary hippocampal
neurons at DIV10. Under a constant Cl− load mediated by a somatic
patch pipette, transport-active KCC2 generates a negative
somatodendritic electrochemical Cl− gradient (Khirug et al.,
2005) (Fig. 4A). We determined ECl− at the soma and at proximal
dendrites and we observed declining somatodendritic Cl− gradients
after treatment with exogenous TGF-β2. Fig. 4B and Fig. S1
illustrate examples of neurons with distinct KCC2 activity. In the
neuron illustrated in Fig. 4A, soma ECl− was −43 mV close to the
calculated value (−50 mV) expected following a constant load with
19 mM [Cl−] through the patch pipette. ECl− in the dendrite was
similar to that of the soma, demonstrating that, in this particular
neuron, KCC2 is not yet active. Treatment with TGF-β2 (arrow)
caused a negative shift in somatodendritic Cl− gradients,
demonstrating effective KCC2-mediated Cl− extrusion activity. In
more mature neurons (see Fig. S1) soma ECl−, was also close to
−50 mV, as expected from the chloride load, but dendrite ECl− was
more negative (−55 mV), due to activated KCC2. Exposure to TGF-
β2 (arrow) caused a small decline in the somatodendritic Cl−
gradient. Somatic and dendritic ECl− in less mature neurons prior to
TGF-β2 treatment were −47.32±2.01 and −46.94±1.71 mV,
respectively, and the somatodendritic Cl− gradient was 0.38±
0.41 mV (mean±s.e.m.; Fig. 4C). TGF-β2 treatment of these
neurons induced a negative shift in the dendritic ECl− of −4.58±
0.62 mV (n=4; dendritic ECl− being −51.51±1.23 mV, P<0.01
when a paired t-test was applied for dendritic ECl− prior to and
during exposure to TGF-β2; Fig. 4C) when measured as an average
over the time window of 20–40 min after onset of TGF-β2
application. The above data demonstrate that TGF-β2 can activate
KCC2, indicated by increased cellular Cl− extrusion.
TGF-β2-induced CREB phosphorylation affects KCC2
trafficking
We next addressed putative mechanisms underlying TGF-β2-
mediated trafficking of KCC2 to the membrane. In rat
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hippocampal neurons TGF-β2 has been shown to induce CREB
phosphorylation (Fukushima et al., 2007). We therefore investigated
protein abundance and cellular distribution of total CREB1 and of
phosphorylated CREB in primary cultured hippocampal neurons
(DIV12) and in neurons exposed to recombinant TGF-β2 for 5, 10
and 15 min. Immunoblot analysis (Fig. 5A) revealed that treatment
with TGF-β2 for 5 min significantly upregulated CREB
phosphorylation, compared to the untreated controls (P<0.05,
n=7; unpaired Student’s t-test). Immunofluorescence (Fig. 5B)
confirmed these data at the cellular level (P<0.01). We next
investigated whether TGF-β2-induced CREB phosphorylation
promotes KCC2 trafficking to the cell membrane. Hippocampal
neurons were transfected either with negative small interfering RNA
(siRNA) or with Alexa-Fluor-488-labeled specific siRNA against
CREB1, as previously described (Oehlke et al., 2012). Cells that had
been exposed to the transfection reagent only served as controls (no
siRNA). After determination of the efficiency of CREB1 transcript
knockdown following transfection (Fig. S2), cells were treated with
TGF-β2 for 60 min and cellular localization of KCC2 (red) was
assessed. Fig. 6 illustrates the KCC2 distribution pattern together
with the corresponding line scans for randomly depicted neurons for
the experimental conditions used. In controls, localization of KCC2
was similar in non-transfected cells (Fig. 6A), in cells transfected
with control negative siRNA (Fig. 6B) and in cells transfected with
specific CREB1 siRNA (Fig. 6C). In these experiments, KCC2
consistently revealed intracellular localization (asterisks and line
scan). After treatment with TGF-β2 (Fig. 6E–G), KCC2 localization
was shifted to the plasma membrane in both non-transfected cells
(Fig. 6E) and in cells transfected with control negative siRNA
(Fig. 6F) (arrows). As shown in representative line scans from cells
Fig. 1. Regulation of KCC2 in neurons at different developmental stages by TGF-β2. (A) Developing (DIV12) cultured mouse hippocampal neurons were
treated with 2 ng/ml TGF-β2 for 60 min. KCC2 transcript (397 bp) expression was normalized to GAPDH by semi-quantitative RT-PCR. Data are given as fold
changes compared to control. (B) DIV12 cultured neurons were treated with TGF-β2 before immunoblotting with anti-KCC2 antibody. Arrows point to the
∼135 kDa and ∼270 kDa KCC2 bands. The ratio of KCC2:GAPDH immunoreactivity was determined. *P=0.016 relative to control as assessed by an
unpaired t-test (n=4). (C,D) DIV12 cultured mouse hippocampal neurons were treated with 2 ng/ml TGF-β2 for 60 min followed by by semi-quantitative RT-PCR
analysis (C) or immunoblotting (D). The ratio of the NKCC1:GAPDH transcript expression (in control set to 1) and the ratio of the NKCC1:GAPDH
immunoreactivity were then determined. (E) Semi-quantitative RT-PCR analysis in more mature (DIV18) cultured mouse hippocampal neurons treated with
2 ng/ml TGF-β2 for 60 min, (n=4). (F) Immunoblot analysis for ∼135 kDa (arrow) and ∼270 kDa (arrow) KCC2 protein in cultures of more mature hippocampal
neurons upon TGF-β2 treatment. Data are given as mean±s.e.m. for the indicated number of experiments.
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for each experimental condition, peaks for KCC2 immunolabeling
(arrows) are present at the periphery of neuronal cell bodies,
suggesting labeling of the plasma membrane. In contrast, KCC2
remained localized within the cytosol in cells transfected with
specific CREB1 siRNA (Fig. 6G; asterisk and respective line scan).
Thus, interfering with CREB prevented TGF-β2-mediated KCC2
translocation from intracellular pools to the plasma membrane.
Rab11b mediates TGF-β2-dependent KCC2 trafficking
Rab GTPases are established players of vesicular trafficking
(Hutagalung and Novick, 2011). Rab11b has been shown to
mediate vesicular transport of transmembrane proteins (Silvis et al.,
2009; Oehlke et al., 2011; Butterworth et al., 2012). In addition,
Rab11b has been found in other cellular systems to be under
transcriptional control of CREB (Zhang et al., 2005). We therefore
explored whether Rab11b was a target of TGF-β2 in the transport of
KCC2-carrying vesicles to the neuronal plasma membrane. Using
3D stimulated emission depletion (STED) microscopy, we first
investigated colocalization of KCC2 (red) with Rab11b (green) in
control and TGF-β2 treated DIV12 hippocampal neurons.
Representative pictures at low and high magnification are shown
in Fig. 7. KCC2 colocalization with Rab11b in dendrites of control
neurons (Fig. 7A) was very low, and yellow KCC2–Rab11b clusters
are hardly detectable. In contrast, after TGF-β2 treatment (Fig. 7B),
colocalization of KCC2 with Rab11b in dendrites was considerably
increased, represented by increased appearance of KCC2–Rab11b
yellow clusters (arrows). Quantification of the colocalization
revealed that Pearson’s correlation coefficient was significantly
increased in cells treated with TGF-β2 for 15 min (r=0.148±0.01
and r=0.257±0.07, for controls and TGF-β2-treated neurons,
respectively; P=0.0005, Fig. 7C). Manders’ coefficients M1 and
M2, representing colocalization of KCC2 with Rab11b and Rab11b
with KCC2, respectively, were also significantly increased in TGF-
β2 treated cells [M1, 0.783±0.05 (controls) and 0.921±0.02
(treated), P=0.015; M, 0.614±0.07 (controls) and 0.814±0.05
(treated), P=0.025, Student’s t-test]. In addition, the size of the
KCC2–Rab11b clusters was apparently increased in TGF-β2-
treated cells. We next examined regulation of Rab11b expression in
DIV12 cultured primary hippocampal neurons and in neurons
exposed to TGF-β2 for 5 min to 30 min. Quantitative real-time PCR
analysis (Fig. 7D) revealed that treatment with TGF-β2 significantly
upregulated Rab11b expression with a peak at 10 min.
Confirmation that KCC2 and Rab11b colocalization is
significantly increased in TGF-β2-treated hippocampal neurons
does not necessarily imply that these proteins interact with each
other. To test for a physical association of Rab11b and
KCC2, co-immunoprecipitation experiments were performed. As
illustrated in Fig. 7E, Rab11b co-immunoprecipitated KCC2 in
controls, and TGF-β2 treatment significantly increased the amount
of immunoprecipitated KCC2 (1.00±0.06 and 1.48±0.16 for
controls and TGF-β2-treated cells, respectively; P<0.05, n=3,
Student’s t-test). Vice versa, immunoprecipitation of KCC2
Fig. 2. KCC2 membrane trafficking in hippocampal neurons is controlled by TGF-β2. (A) Mouse hippocampal neurons cultured for 12 days were treated for
60 min with 2 ng/ml TGF-β2, followed by immunolabeling for KCC2 (red) and the Golgi marker Golgi58k (green). The asterisk indicates intracellular KCC2–
Golgi58k colocalization and the arrows point to membrane KCC2 labeling. Scale bar: 10 µm. (B) Colocalization of KCC2 and Golgi58k was quantified by
determination of the Pearson’s correlation coefficient. **P=0.0015 compared to the control condition (unpaired Student’s t-test). (C,D) Cultured neurons were
treated with TGF-β2 for 60 min followed by biotinylation of surface proteins. The ratio of ∼135 kDa surface KCC2:total KCC2, ∼270 kDa surface KCC2:total
KCC2 (C), and of surface NKCC1:total NKCC1 (D) in untreated (Ctl) and TGF-β2-treated cultures were then determined and presented relative to values for
controls (set to 1). *P=0.014 compared to the control condition (unpaired Student’s t-test). Data are given as mean±s.e.m. from three or four independent
experiments as indicated.
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co-immunoprecipitated Rab11b as well, however, without
differences between controls (1.00±0.10 fold) and TGF-β2-treated
cultures (0.96±0.04 fold; n=3). The efficiency of association
between Rab11b and KCC2 is further determined by detection of
the respective input in the co-immunoprecipitation. These data
demonstrate that Rab11b and KCC2 can indeed be associated with
each other in mouse hippocampal neurons and that TGF-β2 might
increase their interaction.
To investigate whether TGF-β2-dependent KCC2 translocation
to the plasma membrane is mediated by Rab11b we knocked down
Rab11b expression, as described previously (Oehlke et al., 2011),
by transfecting the neurons with Alexa-Fluor-488-labeled specific
siRNA against Rab11b (see Fig. S2). Cells that had been exposed to
the transfection reagent only served as controls. Similar to the
results obtained after knockdown of CREB1, cells transfected
with siRNA specific for Rab11b and treated with TGF-β2, revealed
intracellular KCC2 localization (Fig. 6H, asterisk and
corresponding line scan). Thus, interfering with Rab11b
precluded TGF-β2-mediated KCC2 translocation from
intracellular pools to the plasma membrane.
To analyze whether Rab11b acts downstream of CREB, we
determined Rab11b transcript and protein expression following
knockdown of CREB1. As shown in Fig. S2, transfection of cells
with specific siRNA againstCREB1 downregulated Rab11b mRNA
and protein. These data support the notion that Rab11b acts
downstream of CREB and mediates TGF-β2-dependent KCC2
trafficking.
Rab11b mediates TGF-β2-dependent KCC2 functional
expression
To investigate whether the identified molecular pathway TGF-β2–
CREB–Rab11b is the mechanism underlying TGF-β2-depedent
KCC2 activation, we measured somatodendritic Cl− gradients in
cultured neurons transfected with short hairpin RNA against
Fig. 3. TGF-β2 is required for KCC2
trafficking to the membrane in mature
hippocampal neurons. (A) Double
immunofluorescence for KCC2 (red) and
theGolgi marker Golgi58k (green) in DIV18
hippocampal cultures following application
of TGF-β2 (2 ng/ml) for 60 min. Arrows and
asterisk indicate membrane and
intracellular KCC2, respectively. Scale bar:
10 µm. (B) Trafficking of KCC2 was
assessed by determination of
colocalization between KCC2 and
Golgi58k using the Pearson’s correlation
coefficient. After TGF-β2 treatment, the
Pearson’s correlation coefficient for KCC2
and Golgi58k was significantly decreased.
Data are given as mean±s.e.m. from four
independent cultures and experiments.
**P<0.01 (unpaired Student's t-test).
(C) Cultured neurons at DIV18 were treated
with TGF-β2 for 60 min followed by
biotinylation of surface proteins. The ratio
of ∼135 kDa surface KCC2:total KCC2,
∼270 kDa surface KCC2:total KCC2 in
untreated (Ctl) and TGF-β2-treated
cultures were then determined and
presented relative to values for controls (set
to 1). Error bars represent s.e.m.
(D) Double immunofluorescence for KCC2
(red) and the Golgi marker Golgi58k
(green) in DIV18 hippocampal cultures
following application of TGF-β2 (2 ng/ml) or
anti-TGF-β (10 µg/ml) at DIV12 and DIV15.
Line scans illustrate the KCC2 (in red) and
Golgi58K (in green) distribution profile, and
arrows indicate peaks of KCC2
immunofluorescence (representative line
scans from three independent
experiments).
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Rab11b (sh-Rab11b) and with negative control shRNA (Sh-neg)
and treated with TGF-β2 (Fig. 8). In cells transfected with Sh-neg,
treatment with TGF-β2 (arrow) caused a negative shift in
somatodendritic Cl− gradients, demonstrating effective KCC2-
mediated Cl− extrusion activity (Fig. 8B). In contrast, in cells
transfected with Sh-Rab11b (Fig. 8A) application of TGF-β2 had
no effect on the somatodendritic Cl− gradient. The TGF-β2-
induced shift in dendritic ECl- (control) was −5.49±0.8 mV (n=9)
and the somatodendritic gradient in the presence of TGF-β2 was
measured −7.26±2.21 mV (n=5) for the neurons transfected with
Sh negative and −0.03±1.04 mV (n=6) for neurons transfected
with Sh-Rab11b (mean±s.e.m.). These data clearly demonstrate
that Rab11b mediates TGF-β2-dependent functional expression of
KCC2.
Taken together, these results provide evidence that TGF-β2-
dependent KCC2 trafficking and activity to the plasma membrane is
mediated by a signaling cascade that involves CREB and Rab11b.
DISCUSSION
In the present study, we show for the first time that trafficking,
membrane expression and activity of the neuron-specific K+-Cl− co-
transporter KCC2, a key element for the ‘developmental shift’ from
depolarizing to hyperpolarizing GABAergic responses (Rivera
et al., 1999), can be regulated by TGF-β2.
KCC2 functionality has previously been shown to be regulated
by transcriptional control, alternative splicing, trafficking and post-
translational modifications (Blaesse et al., 2009). Meanwhile,
KCC2 has been identified as a crucial molecular player not only
Fig. 4. Treatment with TGF-β2 augments
extrusion of intracellular Cl− from cultured
hippocampal neurons. (A) Schematic
representation of the experimental paradigm for
assessing changes in dendritic chloride extrusion.
GABA is locally applied at the soma and at a
primary dendrite (100 µm distal from the soma) of a
neuron recorded in whole-cell voltage clamp mode
with a pipette containing a slight load of chloride.
The reversal potential in for GABA is estimated in
the two positions. (B) Timecourse of Cl− reversal
potential measured in soma (a) and dendrite (b,c)
of a cultured (DIV 10) hippocampal neuron. Onset
of TGF-β2 application corresponds to time point
zero. In this particular neuron, almost no
somatodendritic Cl− gradient was observed
before exposure to TGF-β2 as the difference in
ECl− measured in soma (a) and in dendrite (b) was
almost zero. After application of TGF-β2, dendritic
ECl− and therefore somatodendritic Cl
− gradient
became negative (c). The insets are example
traces of voltage ramps before (light gray) and
during local application of GABA (dark gray) at the
soma (a) and the dendrites (b,c). The intercept
between these traces gives an estimation of the
GABAA reversal potential at the specific location.
b and a are example traces before and after
application of TGF-β. (C) Quantification of dendritic
ECl− in control and TGF-β2-treated neurons.
*P<0.05 compared to the control (unpaired
Student’s t-test). Error bars represent s.e.m. from
four independent experiments. Data used in this
panel include only those experiments where no
statistically significant difference between somatic
and dendritic ECl− measured in the same cell was
observed prior to TGF-β2 application (Fig. S1).
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during development but also that acts in a transport-independent
mode to promote dendritic spine formation (Li et al., 2007; Gauvain
et al., 2011; Fiumelli et al., 2013; Puskarjov et al., 2014; Llano et al.,
2015). Moreover, impaired synaptic inhibition due to decreased
KCC2 function has been demonstrated in many pathophysiological
conditions, including epilepsy, spasticity and chronic pain
(Boulenguez et al., 2010; Puskarjov et al., 2012; Gagnon et al.,
2013). According to the current view, developmental upregulation
of KCC2 reduces the depolarizing action of GABA; however, this
can be resumed post-traumatically, where neurons likely acquire an
immature state (reviewed in Kaila et al., 2014). Interestingly, during
the past few years, several studies have highlighted that the fast
functional modulation of KCC2 during physiological and
pathophysiological conditions is achieved through post-
translational events rather than regulation of the transporter at the
transcriptional level (Puskarjov et al., 2012; Zhou et al., 2012).
Although some work has shown that the developmental
regulation of KCC2 can be affected by growth factors the
mechanisms underlying regulation of KCC2 in vivo are far from
being understood. Previous experimental evidence has suggested
that KCC2 is transcriptionally regulated by BDNF signaling
through a complex signaling cascade (Rivera et al., 2002, 2004)
but recent observations have demonstrated that in Bdnf−/− mice
developmental upregulation of KCC2 protein and functionality was
comparable to that in the wild type (Puskarjov et al., 2015). In
contrast, BDNF–TrkB signaling was necessary for seizure-induced
post-translational functional activation of KCC2. Indeed, during
development, KCC2 can also be transcriptionally regulated by other
trophic factors such as neurturin (Ludwig et al., 2011) and insulin-
like growth factor (Kelsch et al., 2001). In our previous work, we
have shown impaired GABAergic postsynaptic currents in neurons
of the preBötC of Tgfb2−/− mice (Heupel et al., 2008). We
hypothesize that TGF-β2 is required for the establishment of a
neuronal network by regulating functional expression of KCC2.
TGF-β2 regulates KCC2 membrane trafficking
Our results show that TGF-β2 mode of action on KCC2 apparently
differs from that reported for BDNF, neurtrurin (Ludwig et al.,
2011) and insulin-like growth factor (Kelsch et al., 2001), which are
all capable of upregulating KCC2 mRNA and protein expression in
neurons that are not fully developed. Treatment of hippocampal
differentiating (after 12 days in vitro) neurons with TGF-β2 for
60 min caused a shift in KCC2 immunoreactivity to the periphery of
the neurons, decreased KCC2–Golgi58k colocalization and an
increase in the amount of surface KCC2. Collectively, this argues in
favor of TGF-β2-mediated translocation of KCC2 from intracellular
pools to the plasmamembrane (Fig. 2). To our knowledge, this is the
first demonstration of growth-factor-dependent KCC2 membrane
trafficking. Moreover, TGF-β2 treatment of hippocampal neurons
significantly increased the amount of a ∼270-kDa band, likely
representing oligomeric KCC2 protein. Previous results indicate
that oligomerization is involved in the functional activation of
KCC2 and are in agreement with the potentiating effect of TGF-β2
on the efficacy of chloride extrusion, as discussed below. However,
the question of whether oligomerization of KCC2 is required for
transport activity has not yet been definitively answered (for a
review, see Hartmann and Nothwang, 2015). DIV18 neurons
already express KCC2 in the membrane, and treatment with
exogenous TGF-β2 decreased KCC2–Golgi58k colocalization
(Fig. 3B), without altering the amount of surface KCC2
(Fig. 3C). The effect of exogenous TGF-β2 on KCC2 trafficking
at DIV18 is not detectable due to endogenous TGF-β expression, as
Fig. 5. TGF-β2 activates CREB by
increasing its phosphorylation.
(A) Western blot analysis of total and of
phosphorylated CREB in cultured
hippocampal neurons (DIV12) treated with
2 ng/ml TGF-β2 for either 5, 10 or 15 min
(dotted line represents values for control).
(B) Immunofluorescence for CREB1 and
pCREB of mouse hippocampal cultures
(DIV12) under control conditions and
following treatment with TGF-β2 for 10 min.
Scale bar: 10 µm. Quantification of relative
CREB1 and phospho-CREB fluorescence
intensity following application of TGF-β2 for
5 and 10 min (images are representative out
of four experiments). Data are shown as
mean±s.e.m. for seven or four experiments
as indicated. *P<0.05, **P<0.01 (unpaired
Student’s t-test).
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shown in Fig. 3D. The requirement for TGF-β for KCC2 trafficking
and membrane expression was demonstrated after neutralizing
endogenously expressed TGF-β from DIV12 to DIV18. In these
neurons, KCC2 had not reached the membrane at DIV18,
highlighting the biological significance of TGF-β.
Our data also show that the TGF-β2 effect is specific for KCC2,
given that gene expression, protein abundance and trafficking of
NKCC1 (Fiumelli and Woodin, 2007) are independent of TGF-β2
(Fig. 1). In contrast, BDNF downregulates KCC2 transcript and
protein in an activity-dependent manner in differentiating and
mature hippocampal neurons (Rivera et al., 2002, 2004).
Obviously, the mere presence of plasmalemmal KCC2 protein
in a neuron does not necessarily imply that it is functionally
active. Proof that TGF-β2-induced KCC2 translocation to and
incorporation into the plasma membrane renders KCC2 functional
was provided by assessing the efficacy of neuronal Cl− extrusion
following application of TGF-β2 (Fig. 4). Interestingly, the
potency of exogenous TGF-β2 to regulate KCC2 activity
differed depending whether neurons had already established a
KCC2-dependent Cl− gradient (more mature neurons) or not (less
mature neurons) (Fig. 4B; Fig. S1), matching the biochemical data
in Figs 1 and 2. In neurons that were not mature with inactive
KCC2 (Fig. 4B), TGF-β2 initiated KCC2-mediated Cl− extrusion,
a prerequisite for the ontogenetic change in GABAA-mediated
responses from depolarizing to hyperpolarizing. In mature neurons
with abundant functional KCC2 (Fig. S1), application of TGF-β2
showed a reduced potentiation of KCC2 activity probably
reflecting that KCC2 in these neurons was already working at
nearly maximal efficiency. Interestingly, the Cl− gradient elicited
by TGF-β2 in developing neurons reached a level close to the one
found in mature neurons. These data highlight a distinct mode of
action of TGF-β2 on KCC2 during maturation of neuronal
networks by regulating its trafficking and KCC2-mediated Cl−
transport efficacy.
Fig. 6. Loss-of-function of either CREB or Rab11b impairs TGF-β2-mediated KCC2 trafficking to the plasma membrane. Immunofluorescence for
KCC2 in primary mouse hippocampal neurons transiently transfected with control negative siRNA (neg siRNA, green in B and F), with specific siRNA against
CREB1 (si CREB, green in C and G) or with specific siRNA against Rab11b (si Rab11b, green in D and H). Cells shown in A and E represent non-transfected
neurons. At 24 h following transfection cells were treated with 2 ng/ml TGF-β2 for 60 min. Nuclei were labeled with DAPI (blue). Scale bar: 10 µm. Asterisks
indicate cytosolic KCC2 localization, white arrows point to plasma membrane labeling. The KCC2 distribution profile was visualized by line scans for KCC2
immunofluorescence. Black arrows indicate peaks of KCC2 immunoreactivity. Representative images and line scans are from four independent experiments.
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KCC2 membrane expression has been reported to be regulated
by multiple post translational mechanisms including
(de)phosphorylation (reviewed in Kahle et al., 2013),
oligomerization (Blaesse et al., 2006) and cleavage by proteases
(Puskarjov et al., 2012). Moreover, interaction of KCC2 with the
kainate receptor subunit GluK2 (Mahadevan et al., 2014) and its
auxiliary subunit Neto2 (Ivakine et al., 2013), as well as the adhesion
molecule neuroligin-2 (Sun et al., 2013) might also regulate KCC2
surface expression. However, Neto2-deficient mice have a
comparable reduction of total KCC2 protein and surface KCC2
abundance, suggesting that Neto2 might be required for KCC2
biogenesis and total protein stability rather thanmembrane trafficking
(Mahadevan et al., 2015). Similarly, knockdown of neuroligin-2 in
mouse cortical neurons reduces total KCC2 levels, an effect
accompanied by decreased KCC2 membrane expression and a
delayed GABA functional switch (Sun et al., 2013). By contrast,
subunits of kainate-type glutamate receptors, such as GluK1 and
GluK2, are required for KCC2 oligomerization and surface
expression (Mahadevan et al., 2014). In spinal motoneurons,
activation of 5-HT2A serotonin receptors increases surface KCC2
after spinal cord injury (Bos et al., 2013). In the present study, the
KCC2 mRNA levels were not changed after TGF-β2 treatment.
However, TGF-β2 treatment significantly increased a ∼270 kDa
band without having any significant effect on the total ∼135 kDa
KCC2 protein, suggesting a more complicated multisite TGF-β2-
dependent post-translational mechanism. Thus, the results of the
present study differ from previous reports, our data introduce a
molecular determinant acting predominantly on KCC2 trafficking.
The growth factor TGF-β2 might regulate surface KCC2 expression
and functionality with no net change in total KCC2 mRNA levels.
Fig. 7. Rab11b colocalizes and interacts with KCC2 and its expression depends on TGF-β2. (A,B) 3D STED images illustrating part of dendrite of an
untreated control neuron (inset in A) and a TGF-β2-treated neuron (inset in B) were acquired. Highmagnification images correspond to thewhite-boxed area of the
inset. Scale bar: 500 nm. (C) Pearson’s correlation coefficient and Manders’ coefficients for KCC2 and Rab11b were calculated and were significantly increased
in neurons treated with TGF-β2 for 15 min. ***P=0.0005 for the Pearson’s correlation coefficient, and *P=0.015 and *P=0.025 for M1 and M2, respectively
(unpaired Student’s t-test). (D) DIV12 cultured mouse hippocampal neurons were treated for 5–30 min with 2 ng/ml TGF-β2, followed by quantitative RT-PCR
analysis for Rab11b expression. *P=0.033 for relative Rab11b expression after TGF-β2 application (unpaired Student’s t-test). (E) Interaction of KCC2 with
Rab11b in controls and TGF-β2-treated DIV12 hippocampal neurons. Antibodies against Rab11b were able to immunoprecipitate (IP) KCC2 expressed in
control hippocampal neurons, as detected by immunoblotting with KCC2 antibody. Antibodies against KCC2 were also able to immunoprecipitate Rab11b
expressed in control hippocampal neurons, as detected by immunoblotting with Rab11b antibody. The ratio of ∼135 kDa KCC2:input Rab11b, ∼25 kDa Rab11b:
input KCC2 in untreated (Ctl) and TGF-β2-treated cultures were then determined and presented relative to values for controls (set at 1). The amount of
co-immunoprecipitated KCC2 was significantly increased in TGF-β2-treated neurons, compared to the untreated controls (*P=0.04, unpaired Student’s t-test).
Data are given as mean± s.e.m. from three or four independent experiments as indicated.
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CREB–Rab11b signaling underlies TGF-β2-dependent KCC2
trafficking
Phosphorylation has been proposed as a regulatory mechanism for
KCC2 trafficking. PKC-dependent phosphorylation of KCC2
(S940) increases its cell surface expression, whereas Src-mediated
phosphorylation (Y903 and/or Y1087), by regulating KCC2
membrane trafficking, decreases its cell surface stability (Lee
et al., 2010). In the present study we have identified a new signaling
pathway, from TGF-β2 to phosphorylated CREB and Rab11b, as
the underlying mechanism for TGF-β2-mediated KCC2 trafficking
and functional expression. Several lines of experimental evidence
support this view: (1) TGF-β2 induced phosphorylation of CREB at
S133 (Fig. 5) and increased Rab11b transcription in cultured mouse
hippocampal neurons (Fig. 7); (2) TGF-β2 treatment increased
KCC2–Rab11b colocalization (Fig. 7C) and their interaction
(Fig. 7E); (3) either CREB1 or Rab11b knockdown significantly
impaired TGF-β2-induced KCC2 trafficking (Fig. 6); (4)
knockdown of CREB1 downregulated Rab11b transcript and
protein (Fig. S2); and (5) knockdown of Rab11b abolished TGF-
β2-mediated KCC2 activity by means of KCC2-mediated
Cl− transport efficacy (Fig. 8). TGF-β-dependent CREB
phosphorylation and its physiological significance have been
studied in many non-neural paradigms, including epithelial-
mesenchymal transition, tumor growth inhibition (Yang et al.,
2013) and fibronectin expression in mesangial cells (Peng et al.,
2008). In contrast, little is known on the impact of TGF-β-dependent
CREB phosphorylation in neurons. TGF-β1 enhances CREB
phosphorylation in Aplysia sensory neurons in a MAPK-
dependent manner (Chin et al., 2006), and TGF-β2 induces
CREB phosphorylation in rat hippocampal neurons (Fukushima
et al., 2007). The latter observation has been postulated as the
mechanism underlying TGF-β2-dependent modulation of synaptic
efficacy and plasticity, however, the causative link is missing. The
present study, for the first time, deciphers a putative biological role
of TGF-β2-dependent CREB phosphorylation in neurons. Our data
propose a scenario, in which TGF-β2 could activate CREB by
inducing its phosphorylation, which in turn induces Rab11b
expression. Rab11b acting downstream of CREB mediates TGF-
β2-dependent KCC2 trafficking and incorporation in the neuronal
plasma membrane, ultimately leading to activation of KCC2.
Rab11b differentially regulates the trafficking of distinct cargo,
impacts upon plasma membrane expression of several proteins and
is an established regulator of endosomal recycling (Hutagalung and
Novick, 2011). It regulates degradation and decreases the amount of
surface L-type Cav1.2 channels in cardiomyocytes (Best et al.,
2011), whereas it increases surface expression of ENaC in renal
cortical collecting duct cells (Butterworth et al., 2012), of CFTR in
intestinal epithelial cells (Silvis et al., 2009) and of V-ATPase in
salivary duct cells (Oehlke et al., 2011). In contrast, data related to
actions of Rab11b in neurons are scarce. Rab11b is moderately
enriched with the synaptic vesicle fraction of rat hippocampal
neurons (Pavlos et al., 2010), and present in secretory vesicles of
PC12 cells (Khvotchen et al., 2003). Our results show that TGF-β2
treatment leads to KCC2 enrichment after co-immunoprecipitation
with Rab11b, indicating increased KCC2–Rab11b interaction to
facilitate KCC2 trafficking to the membrane. However, the co-
immunoprecipitated KCC2 is only a fraction of total KCC2, a pool
of KCC2 that does not interact with Rab11b is still present. The
latter fraction is included when immunoprecipitation for KCC2 is
performed. This fact, together with the result that TGF-β2 treatment
increases Rab11b expression but not KCC2 expression, likely
explains the lack of enrichment of Rab11b after co-
immunoprecipitation with KCC2 (Fig. 7E). Taken together, our
results provide the first evidence for a crucial physiological role of
Rab11b in neurons, by regulating trafficking of KCC2 to the
membrane.
In summary, we introduce TGF-β2 as a new regulator of the
neuronal KCC2 membrane trafficking, membrane expression and
activity and provide mechanistic insight by identifying CREB and
Rab11b as molecular determinants underlying TGF-β2-dependent
KCC2 trafficking and activity. We propose an overall requirement
for TGF-β2 for the developmental shift of GABAergic transmission
and the development of a functional neuronal network.
MATERIALS AND METHODS
Animals
All protocols were carried out in accordance with German ethical guidelines
for laboratory animals and approved by the Institutional Animal Care and
Use Committee of the University of Freiburg (authorizations: X-10/27S and
X-10/08S). Adult C57BL/6N mice of either sex were maintained on a 12-h-
dark–12-h-light cycle with food and water ad libitum. Mice were killed by
cervical dislocation and all efforts were made to minimize suffering.
Primary cultures of mouse E18.5 hippocampal neurons
Hippocampal neurons were isolated from C57Bl6 mice at embryonic day
(E)18.5 of gestation, as described previously (Lacmann et al., 2007).
Cultures were treated with human recombinant TGF-β2 (2 ng/ml; R&D
Systems) for 5, 10, 15, 30 and 60 min or with a pan-TGF-β antibody (a
function-blocking anti-TGF-β1, -β2 and -β3 antibody; 10 µg/ml; cat. no.
Fig. 8. Rab11b mediates TGF-β2-dependent KCC2 functional expression. (A) Somatodendritic Cl− gradients measured in cultured neurons (DIV10–15)
transfected with Sh-Rab11b (n=6 independent experiments) and treated with TGF-β2. (B) Somatodendritic Cl− gradients measured in cultured neurons (DIV10-
15) transfected with Sh-neg (n=5 independent experiments). Control cells (n=9) include those characterized in Fig. 4. (C) Quantification of EGABA gradient after
TGF-β2 application. **P<0.01 compared to the controls, ##P<0.01 compared to Sh-Rab11b (unpaired Student’s t-test). Statistical analysis for the cells transfected
with Sh-Rab11b includes only those experiments where the ‘external control’ was positive, i.e. non-transfected cells from the same coverslip showed a clear
difference in somatic and dendritic ECl−. Data are shown as mean±s.e.m. for the indicated number of experiments.
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MAB1835, R&D Systems). At day in vitro (DIV)12, or DIV18 cells were
processed for RT-PCR, immunoblotting or immunocytochemistry.
Efficacy of KCC2-mediated Cl− extrusion
KCC2-mediated Cl− extrusion in hippocampal neurons was determined as
described previously (Khirug et al., 2005). The assay of neuronal Cl−
extrusion is based on imposing a somatic chloride load through a whole-cell
patch-clamp electrode and measuring the somato-dendritic gradient of the
reversal potential of GABAA receptor-mediated current responses (EGABA)
induced along the dendrite by local iontophoretic application of GABA.
Somatic recordings in immature cultured hippocampal neurons (DIV 10–
14) were performed in standard extracellular solution at room temperature in
the whole-cell voltage-clamp configuration using a patch-clamp amplifier,
according to Khirug et al. (2005). For local iontophoretic application of
GABA, brief (100 ms) positive current pulses (30–100 nA) were delivered
by a sharp micropipette (100–200 MOhm when filled with 250 mMGABA
in 250 mMHCl). Iontophoretic GABA injections were given not more often
than once in 2 min. Constant negative current of −4 nA was applied to the
micropipette in order to compensate for the passive leak of GABA. GABA
was applied at the soma and at the dendrite (∼100 μm from the soma) of a
given neuron. NKCC1 was blocked throughout the experiments with 10 μM
bumetanide, action potentials with 1 μM TTX and GABAB receptors with
1 μM CGP 55845 (Tocris Bioscience). Under these conditions, the
somatodendritic gradient of EGABA provides a quantitative estimate of the
efficacy of KCC2-mediated Cl− extrusion.
Immunocytochemistry
Cells were fixed with methanol for 20 min at −20°C or with 4%
paraformaldehyde (PFA) for 30 min and washed three times with PBS for
5 min. For double immunofluorescence, cells were treated for 15 min with
1% bovine serum albumin (BSA), followed by incubation with primary
antibodies [anti-KCC2 at 1:1500 (C2366, Sigma Aldrich, Seelze,
Germany), anti-Golgi58K at 1:75 (G 2404, Clone 58K-9, Sigma Aldrich,
Seelze, Germany), anti-CREB at 1:500 (48H2, New England Biolabs,
Frankfurt/Main, Germany), anti-phospho-CREB 1:50 (87G3, New England
Biolabs, Frankfurt/Main, Germany), anti-Rab11b 1:250 (BO2P, Abnova,
Taipei city, Taiwan)] overnight at 4°C. Cells were incubated with goat anti-
rabbit-IgG coupled to Alexa Fluor 568 (1:500) and goat anti-mouse-IgG
coupled to Alexa Fluor 488 (1:200) (Jackson Immuno Research, Suffolk,
UK) for 1 h at room temperature. Cells were washed with PBS, coverslips
mounted with Vectashield and viewed either with a Zeiss Axioplan2
fluorescence microscope with ApoTome module or with a Leica confocal
SP8 microscope (Wetzlar, Germany).
Immunoblotting
Primary hippocampal neurons were washed with ice-cold homogenizing
buffer containing (in mM) 280 mannitol, 10 HEPES, 10 KCl, 1 MgCl2,
adjusted to pH 7.0 and a protease inhibitor cocktail (10 µM leupeptin, 2 mM
benzamidine and 0.1 mM Pefabloc®SC), scraped off the culture flasks with
a rubber policeman, pelleted by centrifugation at 250 g for 5 min and
resuspended in homogenization buffer. Homogenization was performed by
sonication. Protein concentration was determined according to Bradford
(1976) and samples were processed for immunoblotting. Electrophoresis
and blotting procedures were performed as previously described (Brandes
et al., 2007). Blots were incubated with primary antibody overnight at
dilution 1:5000 for KCC2, 1:4000 for α1 subunit of Na+/K+-ATPase (05-
369, Upstate/Millipore, Schwalbach, Germany), 1:2000 for NKCC1
(AB3560P, Upstate/Millipore, Schwalbach, Germany) and β-III-tubulin
(Developmental Studies Hybridoma Bank, IA), 1:1000 for CREB and
phosphorylated (p)CREB, and 1:10,000 for GAPDH [ab8245 (6C5),
Abcam, Cambridge, UK]. After incubation with secondary antibodies
(Amersham, GE Healthcare, Freiburg, Germany), blots were developed in
enhanced chemiluminescence reagents and signals were visualized on X-ray
film. Subsequently, films were scanned using a flat-bed scanner and the
signal ratios for KCC2:GAPDH, NKCC1:GAPDH, KCC2:Na+/K+-ATPase
and pCREB:CREB was quantified densitometrically for controls and TGF-
β2-treated cells. The signal ratios for KCC2:GAPDH, NKCC1:GAPDH,
KCC2:Na+/K+-ATPase, pCREB:CREB for untreated cells was set to
1. Relative protein abundance (signal ratio of treated cells/signal ratio of
untreated cells, i.e. fold change) of the protein of interest was then plotted.
Surface biotinylation
Hippocampal cultures were subjected to control or experimental conditions
(application of recombinant TGF-β2) and then kept on ice. Isolation of cell
surface proteins was performed using the Pierce® (Thermo Fisher Scientific)
cell surface protein isolation kit following the manufacturer’s instructions.
Proteins were then processed for immunoblotting with antibody against
KCC2, NKCC1 and Na+/K+-ATPase, as described above.
Immunoprecipitation
Immunoprecipitation was performed as described previously (Oehlke et al.,
2011). Hippocampal neurons at DIV12 were scrapped off a Petri dish into
500 µl non-denaturing lysis buffer [50 mMTris-HCl pH 7.4, 300 mMNaCl,
5 mM EDTA, 1%Triton X-100, CompleteTM proteinase cocktail (Roche
Diagnostics, Mannheim, Germany) and 0.1 mM Pefabloc®SC]. Cells were
pelleted by centrifugation at 250 g for 5 min and resuspended in non-
denaturing lysis buffer. Efficient homogenization was assured by
sonication. Protein concentration was determined according to Bradford
(1976). Total protein (500 µg) was mixed with 75 µl protein-A–Sepharose
beads (Invitrogen, Carlsbad, CA; 1:1 in immunoprecipitation buffer, i.e.
non-denaturing lysis buffer containing 0.1% Triton X-100) and incubated
overnight at 4°C with agitation. After centrifugation for 5 min at 2300 g to
remove proteins non-specifically bound to protein-A–Sepharose, the
precleared cell lysate was added to antibody-conjugated beads and
incubated overnight at 4°C with permanent agitation. To prepare
antibody-conjugated beads, 3 µg of antibody (KCC2 or Rab11b) and
20 µl 1% BSA in immunoprecipitation buffer were added to 75 µl of
protein-A–Sepharose beads and incubated overnight at 4°C. The beads were
spun down for 5 min at 2300 g and the precleared cell lysate was added as
described above. Subsequently, the beads were spun down, washed three
times in immunoprecipitation buffer and the supernatant was discarded.
Bound proteins and their interaction partners were resuspended in 30 µl 6×
Laemmli buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 10% glycine, 5%
β-mercaptoethanol, 0.001% Bromophenol Blue), heated for 5 min at 95°C
and immediately cooled down on ice, and processed by SDS-PAGE.
RT-PCR
Total RNA was isolated from hippocampal cells using the Qiagen RNeasy
kit (Qiagen) according to the manufacturer’s instructions, and reverse
transcribed as previously described (Brandes et al., 2007). For detection of
the transcripts, the following protocol was used: denaturation at 95°C for
5 min followed by 35 cycles of PCR amplification performed under the
following conditions: denaturation at 95°C for 30 s, annealing at the
appropriate temperature according to the primer pairs for 45 s, and
elongation at 72°C for 60 s. Final extension at 72°C for 10 min was
terminated by rapid cooling to 4°C. PCR products were analyzed by agarose
gel electrophoresis. Subsequently, the signal ratios for KCC2:GAPDH
and NKCC1:GAPDH were densitometrically analyzed. For PCR, the
following primers were used: GAPDH (Genbank accession number:
NM_008084.3), forward, 5′-CGGCCGCATCTTCTTGTG-3′ nucleotides
(nt 196–213); reverse, 5′-TGACCAGGCGCCCAATAC-3′ (nt 289–272);
for KCC2 (Genbank accession number: NM_020333.2), forward, 5′-CT-
CAACAACCTGACGGACTG-3′ (nt 419–438), reverse, 5′-GCAGAAG-
GACTCCATGATGCCTGCG-3′ (nt 816–797); for NKCC1 (Genbank
accession number NM009194.3), forward, 5′-CATGGTGTCAGGATTT-
GCAC (nt 1893–1912), reverse, 5′-CGTTCAATTCAGCAATCAGG-3′
(nt 2128–2109).
Quantitative real-time PCR
Isolation of total RNA frommouse E18.5 primary hippocampal cultures and
subsequent quantitative real-time PCR was performed as described
previously (Rickmann et al., 2007). Primers and probes were validated by
analysis of a standard curve in a template dissociation curve. Real-time PCR
was performed according to the manufacturer’s instructions (BioRad,
Munich, Germany). Cycle conditions: denaturation at 95°C for 10 min, and
40 cycles of PCR amplification at 95°C for 30 s and at the appropriate
3495
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 3485-3498 doi:10.1242/jcs.189860
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
temperature according to the primer pair for 30 s and elongation at 72°C for
1 min. For qRT-PCR, the following primers were used: CREB (Genebank
accession number NM_001037726.1), forward: 5′-GCCTCTGGTGATG-
TACAAACATACC-3′ (nt 794–818), reverse, 5′-GGGAGGACGCCATA-
ACAACTC-3′ (nt 875–855); for Rab11b (Genebank accession number
NM_008997.3), forward, 5′-GAAGCAAATCGCTGACCGTG-3′ (nt
758–777), reverse, 5′-GCTTGTTGGGTCTCTGTCCA-3′ (nt 858–839);
and forGAPDH (Genebank accession number NM_001289726.1), forward,
5′-TGACGTGCCGCCTGGAGAAA-3′ (nt820-839), reverse, 5′-AGTGT-
AGCCCAAGATGCCCTTCAG-3′ (nt 917–894).
All PCRs were performed in triplicate on a MyiQ Optic I Cycler (Biorad)
The mean±s.d. of the Ct values for Rab11b, CREB, and GAPDH were
determined and analyzed for statistical significance. For documentation of
the data shown in Fig. S2, relative mRNA levels were calculated using the
comparative Ct method (2
−ΔΔCt).
Transient transfection of mouse primary hippocampal cultures
Mouse primary hippocampal neurons grown on coverslips or on six-well
plates were transiently transfected with 100 ng Alexa-Fluor-488-labeled
siRNA specifically targeting mouse Rab11b mRNA, Alexa-Fluor-488-
labeled siRNA specifically targeting CREB1 mRNA (purchased from
Qiagen) or with control (negative) siRNA, a sequence that reveals no
similarity with any known mammalian gene, labeled with Alexa Fluor 488
(AllStars Negative Control siRNA, Qiagen), as previously described
(Oehlke et al., 2011, 2012). Cells solely exposed to the transfection
reagent were considered as controls. Cells were treated with 2 ng/ml TGF-β2
for 60 min at 24 h after transfection, and were harvested and processed for
either RT-PCR or immunocytochemistry. Efficacy of Rab11b and CREB
transcript and protein knockdown was quantified using quantitative real-
time PCR, as described above, and Rab11b and CREB immunolabeling,
respectively. For functional experiments, primary cultures were treated with
1 µg/ml shRNA (SureSilencing shRNA Plasmid for Rat Rab11b from
SABIOSCIENCES (KR43269G GFP carrying plasmid).
Image acquisition and analysis
Images were acquired with a Leica TCS SP8 confocal microscope using a
20×0.75HC PL APO immersion objective lens (to acquire images to
determineCREB andpCREB immunofluorescence intensity followingTGF-
β2 treatment at different time points) and a CS2 63×1.40 oil objective lens (to
acquire images used for calculation of KCC2 fluorescence intensity after
knocking down either Rab11b or CREB). Within each experiment, confocal
microscope settings (laser power, detector gain and amplifier offset) were
kept the same for all scans in which protein expression was compared. Slide
labels were covered and only revealed after data collection. z-stacks of five or
six optical sections with a step size of 0.5 μm were taken for at least five
separate fields of view for each condition to ensure random image collection.
Maximum intensity projections were created from the z-stacks. To quantify
nuclear CREB and pCREB protein expression ImageJ (NIH) was used to
measure the average intensity within the nucleus. After quantification, data
were normalized to the mean of controls (non-treated neurons) in every
experiment. Representative images in each figure were processed identically.
Image acquisition using STED microscopy and analysis
For analysis of colocalization of KCC2 and Rab11b, images were acquired
with Leica TCS SP8 gated stimulated emission depletion (STED 3×)
microscopy using a HCX PLAPO 100×1.40 oil objective lens. Samples
were prepared according to Leica microsystems quick guide with slight
modifications. Briefly, primary hippocampal neurons were plated on
0.17-mm thick coverglass (Harvard apparatus, 64-0713) and maintained
for 12 DIV. After treatment with 2 ng/ml TGF-β2 for 1 h, neurons were
fixed with 4% PFA for 15 min and washed three times with PBS for 5 min.
Cells were blocked with 2% BSA in PBS for 1 h and subsequently,
incubated with mouse monoclonal KCC2 (1:150) and rabbit polyclonal
Rab11b (1:200) antibody overnight at 4°C. The following day, neurons were
incubated with goat anti-mouse IgG coupled to Alexa Fluor 532 (1:100) and
goat anti-rabbit-IgG coupled to tetramethylrhodamine (TRITC) (1:100) for
1 h at room temperature. Cells were washed with PBS, and coverslips were
mounted with Prolong Gold (Molecular Probes).
Within each experiment, identical settings for laser power, STED
power and gate were used to acquire images. The wavelength of the laser
was 660 nm and was adjusted to 50% of power. z-stacks of five or six optical
sections with a step size of 0.21 μm were de-convolved using Huygens
Software. Colocalization of KCC2 with Rab11b was assessed by analysis of
Pearson’s correlation coefficient and Mander’s colocalization coefficient.
The whole cell soma of each condition was used for quantification.
Manders’M1 andM2 coefficients are defined separately for each channel so
that they measure the portion of the intensity in each channel that coincide
with some intensity in the other channel. Pearson’s r-values were calculated
for all planes of the z-stack of each picture, essentially calculating values for
a 3D image. Pictures were visualized with Huygens Surface renderer.
Statistics
No statistical methods were used to pre-determine sample sizes. We used
GraphPad Prism 5 software for statistical analysis. Statistical significance
was assessed with a unpaired two-tailed Student’s t-test unless otherwise
specified and was accepted at the P<0.05 level. The data distributions were
assumed to be normal, but this was not formally tested.
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